Quarterly report · Q3
2931.TEDINET S100PKDZ
Period2022-01-01 → 2022-09-30
Filed2022-11-11
StandardJapan GAAP
ConsolidatedYes
Data checks12 of 12 passed
Key figures · 33
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥32.3bn | 2022-01-01 → 2022-09-30 | Cons. | Net sales |
| Revenue | ¥34.4bn | 2020-10-01 → 2021-12-31 | Cons. | Net sales (5-year summary) |
| Revenue | ¥12.1bn | 2020-10-01 → 2021-06-30 | Cons. | Net sales |
| Operating income | −¥2.3bn | 2022-01-01 → 2022-09-30 | Cons. | Operating income |
| Operating income | −¥844m | 2020-10-01 → 2021-06-30 | Cons. | Operating income |
| Ordinary income | −¥1.1bn | 2022-01-01 → 2022-09-30 | Cons. | Ordinary income |
| Ordinary income | −¥6.4bn | 2020-10-01 → 2021-12-31 | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | −¥440m | 2020-10-01 → 2021-06-30 | Cons. | Ordinary income |
| Profit before tax | −¥654m | 2022-01-01 → 2022-09-30 | Cons. | Income before income taxes |
| Profit before tax | −¥258m | 2020-10-01 → 2021-06-30 | Cons. | Income before income taxes |
| Net income (owners) | −¥873m | 2022-01-01 → 2022-09-30 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | −¥5.0bn | 2020-10-01 → 2021-12-31 | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | −¥296m | 2020-10-01 → 2021-06-30 | Cons. | Profit loss attributable to owners of parent |
| Net income | −¥876m | 2022-01-01 → 2022-09-30 | Cons. | Profit loss |
| Net income | −¥294m | 2020-10-01 → 2021-06-30 | Cons. | Profit loss |
| Total assets | ¥60.1bn | at 2022-09-30 | Cons. | Assets |
| Total assets | ¥61.0bn | at 2021-12-31 | Cons. | Assets |
| Total assets | ¥59.0bn | at 2021-06-30 | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥39.0bn | at 2022-09-30 | Cons. | Liabilities |
| Total liabilities | ¥40.4bn | at 2021-12-31 | Cons. | Liabilities |
| Net assets / equity | ¥21.1bn | at 2022-09-30 | Cons. | Net assets |
| Net assets / equity | ¥20.6bn | at 2021-12-31 | Cons. | Net assets |
| Net assets / equity | ¥24.2bn | at 2021-06-30 | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥11.6bn | at 2022-09-30 | Cons. | Cash and deposits |
| Cash and deposits | ¥9.9bn | at 2021-12-31 | Cons. | Cash and deposits |
| EPS (basic) | ¥-7.81 | 2022-01-01 → 2022-09-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥-3.61 | 2022-07-01 → 2022-09-30d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥-49.07 | 2020-10-01 → 2021-12-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥-3.04 | 2020-10-01 → 2021-06-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥-0.95 | 2021-04-01 → 2021-06-30d | Cons. | Basic earnings loss per share (5-year summary) |
| Equity ratio | 34.4% | at 2022-09-30 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 33.0% | at 2021-12-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 40.6% | at 2021-06-30 | Cons. | Equity to asset ratio (5-year summary) |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 26
| Segment | Item | Period | Value |
|---|---|---|---|
| Reconciling Itemsreconciling | segment profit | 2022-01-01 → 2022-09-30 | −¥1.3bn |
| jpcrp040300-q3r_E27054-000Biofuel Businessreportable segment | revenue | 2022-01-01 → 2022-09-30 | ¥168m |
| jpcrp040300-q3r_E27054-000Biofuel Businessreportable segment | revenue external | 2022-01-01 → 2022-09-30 | ¥168m |
| jpcrp040300-q3r_E27054-000Biofuel Businessreportable segment | segment profit | 2022-01-01 → 2022-09-30 | −¥555m |
| jpcrp040300-q3r_E27054-000Health Care Businessreportable segment | revenue | 2022-01-01 → 2022-09-30 | ¥30.3bn |
| jpcrp040300-q3r_E27054-000Health Care Businessreportable segment | revenue external | 2022-01-01 → 2022-09-30 | ¥30.3bn |
| jpcrp040300-q3r_E27054-000Health Care Businessreportable segment | segment profit | 2022-01-01 → 2022-09-30 | −¥277m |
| jpcrp040300-q3r_E27054-000Others Businessreportable segment | revenue | 2022-01-01 → 2022-09-30 | ¥1.8bn |
| jpcrp040300-q3r_E27054-000Others Businessreportable segment | revenue external | 2022-01-01 → 2022-09-30 | ¥1.8bn |
| jpcrp040300-q3r_E27054-000Others Businessreportable segment | segment profit | 2022-01-01 → 2022-09-30 | −¥197m |
| Total Of Reportable Segments And Otherssegment total | revenue | 2022-01-01 → 2022-09-30 | ¥32.3bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2022-01-01 → 2022-09-30 | ¥32.3bn |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2022-01-01 → 2022-09-30 | −¥1.0bn |
| Reconciling Itemsreconciling | segment profit | 2020-10-01 → 2021-06-30 | −¥1.0bn |
| jpcrp040300-q3r_E27054-000Biofuel Businessreportable segment | revenue | 2020-10-01 → 2021-06-30 | ¥9m |
| jpcrp040300-q3r_E27054-000Biofuel Businessreportable segment | revenue external | 2020-10-01 → 2021-06-30 | ¥9m |
| jpcrp040300-q3r_E27054-000Biofuel Businessreportable segment | segment profit | 2020-10-01 → 2021-06-30 | −¥519m |
| jpcrp040300-q3r_E27054-000Health Care Businessreportable segment | revenue | 2020-10-01 → 2021-06-30 | ¥11.6bn |
| jpcrp040300-q3r_E27054-000Health Care Businessreportable segment | revenue external | 2020-10-01 → 2021-06-30 | ¥11.6bn |
| jpcrp040300-q3r_E27054-000Health Care Businessreportable segment | segment profit | 2020-10-01 → 2021-06-30 | ¥886m |
| jpcrp040300-q3r_E27054-000Others Businessreportable segment | revenue | 2020-10-01 → 2021-06-30 | ¥465m |
| jpcrp040300-q3r_E27054-000Others Businessreportable segment | revenue external | 2020-10-01 → 2021-06-30 | ¥465m |
| jpcrp040300-q3r_E27054-000Others Businessreportable segment | segment profit | 2020-10-01 → 2021-06-30 | −¥205m |
| Total Of Reportable Segments And Otherssegment total | revenue | 2020-10-01 → 2021-06-30 | ¥12.1bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2020-10-01 → 2021-06-30 | ¥12.1bn |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2020-10-01 → 2021-06-30 | ¥161m |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 436
| Item | Context | Value | Unit |
|---|---|---|---|
| Profit loss attributable to owners of parent | Prior1YTDDuration | -296000000 | JPY |
| Profit loss attributable to owners of parent | CurrentYTDDuration | -873000000 | JPY |
| Profit loss | Prior1YTDDuration | -294000000 | JPY |
| Profit loss | CurrentYTDDuration | -876000000 | JPY |
| Valuation difference on available for sale securities net of tax oci | Prior1YTDDuration | -0 | JPY |
| Valuation difference on available for sale securities net of tax oci | CurrentYTDDuration | 4000000 | JPY |
| Foreign currency translation adjustment net of tax oci | Prior1YTDDuration | -6000000 | JPY |
| Foreign currency translation adjustment net of tax oci | CurrentYTDDuration | -17000000 | JPY |
| Remeasurements of defined benefit plans net of tax oci | Prior1YTDDuration | － | JPY |
| Remeasurements of defined benefit plans net of tax oci | CurrentYTDDuration | -1000000 | JPY |
| Share of other comprehensive income of associates accounted for using equity method oci | Prior1YTDDuration | 1000000 | JPY |
| Share of other comprehensive income of associates accounted for using equity method oci | CurrentYTDDuration | 4000000 | JPY |
| Other comprehensive income | Prior1YTDDuration | -5000000 | JPY |
| Other comprehensive income | CurrentYTDDuration | -9000000 | JPY |
| Comprehensive income | Prior1YTDDuration | -300000000 | JPY |
| Comprehensive income | CurrentYTDDuration | -885000000 | JPY |
| Comprehensive income attributable to owners of the parent | Prior1YTDDuration | -298000000 | JPY |
| Comprehensive income attributable to owners of the parent | CurrentYTDDuration | -882000000 | JPY |
| Comprehensive income attributable to non controlling interests | Prior1YTDDuration | -1000000 | JPY |
| Comprehensive income attributable to non controlling interests | CurrentYTDDuration | -2000000 | JPY |
| Revenues from external customers | Prior1YTDDuration_jpcrp040300-q3r_E27054-000HealthCareBusinessReportableSegmentsMember | 11637000000 | JPY |
| Revenues from external customers | Prior1YTDDuration_jpcrp040300-q3r_E27054-000BiofuelBusinessReportableSegmentsMember | 9000000 | JPY |
| Revenues from external customers | Prior1YTDDuration_jpcrp040300-q3r_E27054-000OthersBusinessReportableSegmentsMember | 465000000 | JPY |
| Revenues from external customers | Prior1YTDDuration_TotalOfReportableSegmentsAndOthersMember | 12113000000 | JPY |
| Revenues from external customers | Prior1YTDDuration_ReconcilingItemsMember | － | JPY |
| Revenues from external customers | Prior1YTDDuration | 12113000000 | JPY |
| Transactions with other segments | Prior1YTDDuration_jpcrp040300-q3r_E27054-000HealthCareBusinessReportableSegmentsMember | － | JPY |
| Transactions with other segments | Prior1YTDDuration_jpcrp040300-q3r_E27054-000BiofuelBusinessReportableSegmentsMember | － | JPY |
| Transactions with other segments | Prior1YTDDuration_jpcrp040300-q3r_E27054-000OthersBusinessReportableSegmentsMember | － | JPY |
| Transactions with other segments | Prior1YTDDuration_TotalOfReportableSegmentsAndOthersMember | － | JPY |
| Transactions with other segments | Prior1YTDDuration_ReconcilingItemsMember | － | JPY |
| Transactions with other segments | Prior1YTDDuration | － | JPY |
| Net sales | Prior1YTDDuration_jpcrp040300-q3r_E27054-000HealthCareBusinessReportableSegmentsMember | 11637000000 | JPY |
| Net sales | Prior1YTDDuration_jpcrp040300-q3r_E27054-000BiofuelBusinessReportableSegmentsMember | 9000000 | JPY |
| Net sales | Prior1YTDDuration_jpcrp040300-q3r_E27054-000OthersBusinessReportableSegmentsMember | 465000000 | JPY |
| Net sales | Prior1YTDDuration_TotalOfReportableSegmentsAndOthersMember | 12113000000 | JPY |
| Net sales | Prior1YTDDuration_ReconcilingItemsMember | － | JPY |
| Net sales | Prior1YTDDuration | 12113000000 | JPY |
| Operating income | Prior1YTDDuration_jpcrp040300-q3r_E27054-000HealthCareBusinessReportableSegmentsMember | 886000000 | JPY |
| Operating income | Prior1YTDDuration_jpcrp040300-q3r_E27054-000BiofuelBusinessReportableSegmentsMember | -519000000 | JPY |
| Operating income | Prior1YTDDuration_jpcrp040300-q3r_E27054-000OthersBusinessReportableSegmentsMember | -205000000 | JPY |
| Operating income | Prior1YTDDuration_TotalOfReportableSegmentsAndOthersMember | 161000000 | JPY |
| Operating income | Prior1YTDDuration_ReconcilingItemsMember | -1005000000 | JPY |
| Operating income | Prior1YTDDuration | -844000000 | JPY |
| Direct sales | CurrentYTDDuration_jpcrp040300-q3r_E27054-000HealthCareBusinessReportableSegmentsMember | 25696000000 | JPY |
| Direct sales | CurrentYTDDuration_jpcrp040300-q3r_E27054-000BiofuelBusinessReportableSegmentsMember | － | JPY |
| Direct sales | CurrentYTDDuration_jpcrp040300-q3r_E27054-000OthersBusinessReportableSegmentsMember | － | JPY |
| Direct sales | CurrentYTDDuration_TotalOfReportableSegmentsAndOthersMember | 25696000000 | JPY |
| Direct sales | CurrentYTDDuration_ReconcilingItemsMember | － | JPY |
| Direct sales | CurrentYTDDuration | 25696000000 | JPY |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 12 of 12 passed
| balance sheet identity | pass rounding |
| balance sheet identity | pass rounding |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |